These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8688399)

  • 1. Double-blind evaluation of ritodrine sustained release for oral maintenance of tocolysis after active preterm labour.
    Holleboom CA; Merkus JM; van Elferen LW; Keirse MJ
    Br J Obstet Gynaecol; 1996 Jul; 103(7):702-5. PubMed ID: 8688399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ritodrine in oral maintenance of tocolysis after active preterm labor: randomized controlled trial.
    Matijević R; Grgić O; Vasilj O
    Croat Med J; 2006 Feb; 47(1):25-31. PubMed ID: 16489694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomised comparison between a loading and incremental dose model for ritodrine administration in preterm labour.
    Holleboom CA; Merkus JM; van Elferen LW; Keirse MJ
    Br J Obstet Gynaecol; 1996 Jul; 103(7):695-701. PubMed ID: 8688398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicentre, parallel group, randomised, single-blind study of the safety and efficacy of atosiban versus ritodrine in the treatment of acute preterm labour in Korean women.
    Shim JY; Park YW; Yoon BH; Cho YK; Yang JH; Lee Y; Kim A
    BJOG; 2006 Nov; 113(11):1228-34. PubMed ID: 16978233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nifedipine and ritodrine in the management of preterm labor: a randomized multicenter trial.
    Papatsonis DN; Van Geijn HP; Adèr HJ; Lange FM; Bleker OP; Dekker GA
    Obstet Gynecol; 1997 Aug; 90(2):230-4. PubMed ID: 9241299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. The Worldwide Atosiban versus Beta-agonists Study Group.
    Worldwide Atosiban versus Beta-agonists Study Group
    BJOG; 2001 Feb; 108(2):133-42. PubMed ID: 11236112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness and safety of ritodrine hydrochloride for the treatment of preterm labour: a systematic review.
    Yaju Y; Nakayama T
    Pharmacoepidemiol Drug Saf; 2006 Nov; 15(11):813-22. PubMed ID: 16981213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral betamimetics for maintenance therapy after threatened preterm labour.
    Dodd JM; Crowther CA; Middleton P
    Cochrane Database Syst Rev; 2012 Dec; 12(12):CD003927. PubMed ID: 23235600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biopharmaceutical aspects of ritodrine retard in pregnant women.
    Essed GG; Struyker Boudier HA; Van Zijl JA
    Arch Int Pharmacodyn Ther; 1988; 293():295-300. PubMed ID: 3421783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glyceryl trinitrate and ritodrine in tocolysis: an international multicenter randomized study. GTN Preterm Labour Investigation Group.
    Lees CC; Lojacono A; Thompson C; Danti L; Black RS; Tanzi P; White IR; Campbell S
    Obstet Gynecol; 1999 Sep; 94(3):403-8. PubMed ID: 10472868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between total dose of ritodrine hydrochloride and pulmonary oedema in twin pregnancy: a retrospective cohort study in Japan.
    Shinohara S; Sunami R; Uchida Y; Hirata S; Suzuki K
    BMJ Open; 2017 Dec; 7(12):e018118. PubMed ID: 29289935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The NIFTY study: a multicentre randomised double-blind placebo-controlled trial of nifedipine maintenance tocolysis in fetal fibronectin-positive women in threatened preterm labour.
    Parry E; Roos C; Stone P; Hayward L; Mol BW; McCowan L
    Aust N Z J Obstet Gynaecol; 2014 Jun; 54(3):231-6. PubMed ID: 24506318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A loading model for ritodrine administration in preterm labour.
    Holleboom CA; Merkus JM; van Elferen LW; Keirse MJ
    Br J Obstet Gynaecol; 1993 Dec; 100(12):1107-10. PubMed ID: 8297844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-week delayed delivery in a triplet pregnancy at full dilatation with aggressive tocolysis.
    Oyelese Y; Holden D; Hamid R; Ville Y
    J Matern Fetal Med; 2000; 9(4):250-1. PubMed ID: 11048839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicenter evaluation of intramuscular ritodrine hydrochloride as initial parenteral therapy for preterm labor management.
    Benedetti TJ; Gonik B; Hayashi RH; Adams HJ
    J Perinatol; 1994; 14(5):403-7. PubMed ID: 7830157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nifedipine versus ritodrine for suppression of preterm labor. Comparison of their efficacy and secondary effects.
    Cararach V; Palacio M; Martínez S; Deulofeu P; Sánchez M; Cobo T; Coll O
    Eur J Obstet Gynecol Reprod Biol; 2006 Aug; 127(2):204-8. PubMed ID: 16310305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral ritodrine maintenance in the treatment of preterm labor.
    Creasy RK; Golbus MS; Laros RK; Parer JT; Roberts JM
    Am J Obstet Gynecol; 1980 May; 137(2):212-9. PubMed ID: 6990761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-centre randomised trial of ritodrine hydrochloride for preterm labour.
    Leveno KJ; Klein VR; Guzick DS; Young DC; Hankins GD; Williams ML
    Lancet; 1986 Jun; 1(8493):1293-6. PubMed ID: 2872429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of oral ritodrine and magnesium gluconate for ambulatory tocolysis.
    Martin RW; Martin JN; Pryor JA; Gaddy DK; Wiser WL; Morrison JC
    Am J Obstet Gynecol; 1988 Jun; 158(6 Pt 1):1440-5. PubMed ID: 3381867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective randomized clinical trial comparing a new oral sustained-release ritodrine with conventional tablets.
    Hagay ZJ; Epstein M; Goldchmit R; Gotlib Z; Blickstein I; Zalel Y; Weissman A
    Eur J Obstet Gynecol Reprod Biol; 1994 Aug; 56(2):83-7. PubMed ID: 7805972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.